Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05252858 · ClinicalTrials.gov registry record · NA
A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery
A NA study, sponsored by Jacques E. Chelly.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT05252858 is a NA study that has completed, run by Jacques E. Chelly. The registered enrollment target is 79 participants.
The verdict
NCT05252858, a NA study, has completed, sponsored by Jacques E. Chelly.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Opioid addiction in post-operative patients is recognized but not fully understood; therefore, in order to address this growing crisis, it is essential to explore alternative approaches to managing pain and apply them to the surgical population. One potential non-opioid method of pain relief is the use of the nCAP Nano Patch, placed topically on the site of pain. The objective of this study is to investigate the efficacy of the nCAP Signal Relief Patch in reducing the perioperative opioid requirement in patients undergoing primary unilateral total hip or knee replacement surgery.
Interventions
- OTHER Standard of Care
- DEVICE nCAP Signal Relief Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2022-10-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05252858
The ClinicalTrials.gov registry entry for NCT05252858 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jacques E. Chelly, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05252858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05252858 about?
NCT05252858 is a clinical study titled "A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery". Opioid addiction in post-operative patients is recognized but not fully understood; therefore, in order to address this growing crisis, it is essential to explore alternative approaches to managing pain and apply them to the surgical population. One potential non-opioid method of pain relief is the ...
What is the current status of trial NCT05252858?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2022-03-21. Estimated completion is 2022-10-08.
What interventions are being tested in trial NCT05252858?
The interventions under investigation include: Standard of Care (OTHER), nCAP Signal Relief Patch (DEVICE).
Who is sponsoring clinical trial NCT05252858?
This trial is sponsored by Jacques E. Chelly, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.